Sarcopenia in aging, obesity, and cancer
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sarcopenia, defined as a generalized and progressive loss of muscle mass and muscle strength, is a frequent and clinically relevant syndrome in older patients [1], particularly in the oncological setting [2,3].”
In the citing paper
“This is of particular importance in an ageing oncology patient population, since functional status and mobility are key determinants of treatment choice, tolerability, and quality of life [2,3].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Robson, M., Im, S.-A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706450 · Cited by 3,294
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M. J., Park, J.-O., Hochhauser, D., Arnold, D., Oh, D.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903387 · Cited by 2,302 · cited 1×
“Thus, PARP inhibitors need to be further evaluated for impact on sarcopenia, especially in malignancies where they are already part of the therapeutic armamentarium such as breast, ovarian, pancreas, and some cases of prostate cancer (128-131).”
BackgroundFranceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Cruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481 · cited 1×
“Interestingly, dietary supplementation of NAD+ and/or its precursors is currently undergoing extensive investigation to promote healthy aging (132,133), although specific information on sarcopenia is not available.”
BackgroundIliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · cited 2×
“Thus, supplementation with NR to increase NAD+ levels in association with Sirt 1 restores regenerative capacity to muscle stem cells (30).”
BackgroundGeriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010 · cited 3×
“Silencing p16 utilizing an shRNA strategy, resulted in release of satellite cells from the senescence phenotype and restoration of their activation in tissue culture and regenerative capacity upon mouse transfer (29).”
BackgroundMethodInfluentialObesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Iyengar, N. M., Gucalp, A., Dannenberg, A. J., & Hudis, C. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4283 · Cited by 1,004
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890 · cited 1×
“Several studies have shown a slight preponderance of sarcopenia among men compared to women, but others have not (65-67).”
BackgroundAn overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888 · cited 3×
“The elevated inflammatory response and alterations in metabolism related to cancer and cancer treatment lead to further losses of muscle mass (16,17).”
BackgroundJoyner, M. J., & Casey, D. P. (2015) · Physiological Reviews · doi:10.1152/physrev.00035.2013 · Cited by 833 · cited 1×
“In addition, aerobic exercise has been shown to increase muscle vascularity (81,82).”
BackgroundExercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors
Fiuza-Luces, C., Santos-Lozano, A., Joyner, M., Carrera-Bastos, P., Picazo, O., Zugaza, J. L., Izquierdo, M., Ruilope, L. M., & Lucia, A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0065-1 · Cited by 803
Inflammation and sarcopenia: A systematic review and meta-analysis
Bano, G., Trevisan, C., Carraro, S., Solmi, M., Luchini, C., Stubbs, B., Manzato, E., Sergi, G., & Veronese, N. (2017) · Maturitas · doi:10.1016/j.maturitas.2016.11.006 · Cited by 801
Exercise is the real polypill.
Fiuza-Luces, C., Garatachea, N., Berger, N. A., & Lucia, A. (2013) · Physiology · doi:10.1152/physiol.00019.2013 · Cited by 791
Self-citationThe Role of Inflammation in Age-Related Sarcopenia
Dalle, S., Rossmeislova, L., & Koppo, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01045 · Cited by 668
Ferrucci, L., Penninx, B. W. J. H., Volpato, S., Harris, T. B., Bandeen‐Roche, K., Balfour, J., Leveille, S. G., Fried, L. P., & Md, J. M. G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50605.x · Cited by 618
Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588
Weight lifting in women with breast-cancer-related lymphedema
Schmitz, K. H., Ahmed, R. L., Troxel, A., Cheville, A., Smith, R., Lewis-Grant, L., Bryan, C. J., Williams-Smith, C. T., & Greene, Q. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810118 · Cited by 578 · cited 1×
“Exercise trials have documented improved body composition after treatment completion (126,127), but very few have focused specifically on older adults.”
BackgroundSelf-citationPathogenesis and Management of Sarcopenia
Dhillon, R. J. S., & Hasni, S. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.08.002 · Cited by 574 · cited 1×
“Functional tests of muscle strength usually involve hand grip and/or gait speed (45,56).”
BackgroundMinnella, E. M., Awasthi, R., Loiselle, S.-E., Agnihotram, R. V., Ferri, L. E., & Carli, F. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1645 · Cited by 522 · cited 1×
“There is compelling evidence that prehabilitation interventions among esophagogastric, colorectal, lung and liver cancer patients result in improved functional outcomes (119-122).”
BackgroundGustafsson, U. O., Rockall, T. A., Wexner, S., How, K. Y., Emile, S., Marchuk, A., Fawcett, W. J., Sioson, M., Riedel, B., Chahal, R., et al. (2025) · Surgery · doi:10.1016/j.surg.2025.109397 · Cited by 487
Fry, C. S., Lee, J. D., Mula, J., Kirby, T. J., Jackson, J. R., Liu, F., Yang, L., Mendias, C. L., Dupont-Versteegden, E. E., McCarthy, J. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3710 · Cited by 432
Chronic low-grade inflammation and age-related sarcopenia
Beyer, I., Mets, T., & Bautmans, I. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834dd297 · Cited by 400 · cited 3×
“Obesity is a chronic low grade inflammatory disorder (metaflammation) generating altered levels of cytokines and adipokines, including increased IL-6, MCP-1, TNFα, leptin, and decreased adiponectin (87), all of which may contribute to general muscle inflammation (88,89).”
BackgroundFatty infiltration of skeletal muscle: mechanisms and comparisons with bone marrow adiposity
Hamrick, M. W., McGee-Lawrence, M. E., & Frechette, D. M. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00069 · Cited by 372 · cited 1×
“Obesity also leads to insulin resistance and leptin resistance, each of which can impair muscle metabolism and lead to fatty infiltration of muscle (myosteatosis) (86,90).”
BackgroundDieli-Conwright, C. M., Courneya, K. S., Demark-Wahnefried, W., Sami, N., Lee, K., Buchanan, T. A., Spicer, D. V., Tripathy, D., Bernstein, L., & Mortimer, J. E. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.7526 · Cited by 366 · cited 1×
“21037/tcr-2019-eaoc-05 incorporate resistance training exercise lead to increased muscle mass and prevention of clinically significant decline during and after cancer treatment (92,116,117).”
BackgroundMigliavacca, E., Tay, S. K. H., Patel, H. P., Sonntag, T., Civiletto, G., McFarlane, C., Forrester, T., Barton, S. J., Leow, M. K., Antoun, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13694-1 · Cited by 365 · cited 2×
“By preserving NAD+ pools, PARP inhibitors, commonly used in chemotherapy, can improve mitochondrial metabolism, which may preserve muscle mass (34-40).”
BackgroundNicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Mitchell, S. J., Bernier, M., Aon, M. A., Cortassa, S., Kim, E. Y., Fang, E. F., Palacios, H. H., Ali, A., Navas-Enamorado, I., Di Francesco, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.001 · Cited by 338 · cited 1×
“Interestingly, dietary supplementation of NAD+ and/or its precursors is currently undergoing extensive investigation to promote healthy aging (132,133), although specific information on sarcopenia is not available.”
BackgroundPirinen, E., Cantó, C., Jo, Y. S., Morato, L., Zhang, H., Menzies, K. J., Williams, E. G., Mouchiroud, L., Moullan, N., Hagberg, C., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.002 · Cited by 254 · cited 2×
“By preserving NAD+ pools, PARP inhibitors, commonly used in chemotherapy, can improve mitochondrial metabolism, which may preserve muscle mass (34-40).”
BackgroundScott, D., Blizzard, L., Fell, J., Giles, G., & Jones, G. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03147.x · Cited by 228
Cawthon, P. M., Orwoll, E. S., Peters, K. E., Ensrud, K. E., Cauley, J. A., Kado, D. M., Stefanick, M. L., Shikany, J. M., Strotmeyer, E. S., Glynn, N. W., et al. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/gly129 · Cited by 213 · cited 1×
“D3-Cr measured muscle mass has been shown to correlate with short physical performance battery (SPPB) and mobility limitation in older men (51).”
BackgroundLevine, M. E., & Crimmins, E. M. (2012) · Obesity · doi:10.1038/oby.2012.20 · Cited by 186 · cited 2×
“Obesity also leads to insulin resistance and leptin resistance, each of which can impair muscle metabolism and lead to fatty infiltration of muscle (myosteatosis) (86,90).”
BackgroundTotal body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans
Clark, R. V., Walker, A. C., O'Connor-Semmes, R. L., Leonard, M. S., Miller, R. R., Stimpson, S. A., Turner, S. M., Ravussin, E., Cefalu, W. T., Hellerstein, M. K., et al. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00045.2014 · Cited by 176
Du, Y., Wang, X., Xie, H., Zheng, S., Wu, X., Zhu, X., Zhang, X., Xue, S., Li, H., Hong, W., et al. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0432-x · Cited by 175 · cited 1×
“Several studies have shown a slight preponderance of sarcopenia among men compared to women, but others have not (65-67).”
BackgroundFarsijani, S., Morais, J. A., Payette, H., Gaudreau, P., Shatenstein, B., Gray-Donald, K., & Chevalier, S. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.130716 · Cited by 136 · cited 3×
“While there is great inter-individual variation in the development of sarcopenia, the major contributing lifestyle factors in older adults, appear to be insufficient dietary protein intake and reduced physical activity (71-74).”
BackgroundComparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06831-7 · Cited by 86
Clark, R. V., Walker, A. C., Miller, R. R., O’Connor-Semmes, R. L., Ravussin, E., & Cefalu, W. T. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00455.2016 · Cited by 67
New Molecular Targets and Lifestyle Interventions to Delay Aging Sarcopenia
Sanchis-Gomar, F., Pareja-Galeano, H., Mayero, S., Perez-Quilis, C., & Lucia, A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00156 · Cited by 24
Cited by
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Papadopetraki, A., Giannopoulos, A., Maridaki, M., Zagouri, F., Droufakou, S., Koutsilieris, M., & Philippou, A. (2023) · Cancers · doi:10.3390/cancers15245856 · Cited by 34
“This CSA divided by the square of the individual’s height represents the skeletal muscle index (SMI; cm 2 /m 2 ) [37,40].”
BackgroundMethodBüntzel, S. K., Büthe, L., Sulzer, S., Büntzel, J., & Büntzel, J. (2026) · Nutrients · doi:10.3390/nu18213550
Metadata
- Authors
- Ligibel, J. A., Schmitz, K. H., & Berger, N. A.
- Venue
- Translational Cancer Research
- Publisher
- AME Publishing Company
- Published
- 2020-09
- Volume
- 9
- Issue
- 9
- Pages
- 5760-5771
- ISSN
- 2218-676X
- 2219-6803
- Cited by
- 53
- References
- 45
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.